Literature DB >> 26958506

PiggyBac transposon vectors: the tools of the human gene encoding.

Shuang Zhao1, Enze Jiang1, Shuangshuang Chen1, Yuan Gu1, Anna Junjie Shangguan1, Tangfeng Lv1, Liguo Luo1, Zhenghong Yu1.   

Abstract

A transposon is a DNA segment, which is able to change its relative position within the entire genome of a cell. The piggyBac (PB) transposon is a movable genetic element that efficiently transposes between vectors and chromosomes through a "cut-and-paste" mechanism. During transposition, the PB transposase recognizes transposon-specific inverted terminal repeats (ITRs) sequences located on both ends of the transposon vector and eight efficiently moves the contents from its original positions and efficiently integrates them into TTAA chromosomal sites. PB has drawn much attention because of its transposition efficiency, safety and stability. Due to its priorities, PB can be used as a new genetic vehicle, a new tool for oncogene screening and a new method for gene therapy. PB has created a new outlook for human gene encoding.

Entities:  

Keywords:  PiggyBac (PB); transgene; transposon

Year:  2016        PMID: 26958506      PMCID: PMC4758974          DOI: 10.3978/j.issn.2218-6751.2016.01.05

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  30 in total

1.  Chimeric Mos1 and piggyBac transposases result in site-directed integration.

Authors:  K J Maragathavally; J M Kaminski; C J Coates
Journal:  FASEB J       Date:  2006-07-28       Impact factor: 5.191

2.  piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells.

Authors:  Sareina Chiung-Yuan Wu; Yaa-Jyuhn James Meir; Craig J Coates; Alfred M Handler; Pawel Pelczar; Stefan Moisyadi; Joseph M Kaminski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-27       Impact factor: 11.205

3.  Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer.

Authors:  Andrew Wilber; Jonathan L Linehan; Xinghui Tian; Petter S Woll; Julie K Morris; Lalitha R Belur; R Scott McIvor; Dan S Kaufman
Journal:  Stem Cells       Date:  2007-08-02       Impact factor: 6.277

4.  A gene delivery system for human cells mediated by both a cell-penetrating peptide and a piggyBac transposase.

Authors:  Cheng-Yi Lee; Jheng-Fong Li; Ji-Sing Liou; Yuh-Chyang Charng; Yue-Wern Huang; Han-Jung Lee
Journal:  Biomaterials       Date:  2011-06-01       Impact factor: 12.479

5.  Manipulating piggyBac transposon chromosomal integration site selection in human cells.

Authors:  Claudia Kettlun; Daniel L Galvan; Alfred L George; Aparna Kaja; Matthew H Wilson
Journal:  Mol Ther       Date:  2011-07-05       Impact factor: 11.454

6.  piggyBac can bypass DNA synthesis during cut and paste transposition.

Authors:  Rupak Mitra; Jennifer Fain-Thornton; Nancy L Craig
Journal:  EMBO J       Date:  2008-03-20       Impact factor: 11.598

7.  Genome-wide target profiling of piggyBac and Tol2 in HEK 293: pros and cons for gene discovery and gene therapy.

Authors:  Yaa-Jyuhn J Meir; Matthew T Weirauch; Herng-Shing Yang; Pei-Cheng Chung; Robert K Yu; Sareina C-Y Wu
Journal:  BMC Biotechnol       Date:  2011-03-30       Impact factor: 2.563

8.  Mutational analysis of highly conserved aspartate residues essential to the catalytic core of the piggyBac transposase.

Authors:  James H Keith; Cheryl A Schaeper; Tresa S Fraser; Malcolm J Fraser
Journal:  BMC Mol Biol       Date:  2008-08-11       Impact factor: 2.946

9.  Generation of an inducible and optimized piggyBac transposon system.

Authors:  Juan Cadiñanos; Allan Bradley
Journal:  Nucleic Acids Res       Date:  2007-06-18       Impact factor: 16.971

10.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.

Authors:  Knut Woltjen; Iacovos P Michael; Paria Mohseni; Ridham Desai; Maria Mileikovsky; Riikka Hämäläinen; Rebecca Cowling; Wei Wang; Pentao Liu; Marina Gertsenstein; Keisuke Kaji; Hoon-Ki Sung; Andras Nagy
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

View more
  15 in total

1.  Multiple dengue virus serotypes resistant transgenic Aedes aegypti fitness evaluated under laboratory conditions.

Authors:  Hewawasam Patuwatha Badathuruge Kalindu Dulanja Ramyasoma; Ranil Samantha Dassanayake; Menaka Hapugoda; Margareth L Capurro; Yasanthi Illika Nilmini Silva Gunawardene
Journal:  RNA Biol       Date:  2020-03-06       Impact factor: 4.652

2.  Efficient Generation of Stable Cell Lines with Inducible Neuronal Transgene Expression Using the piggyBac Transposon System.

Authors:  Jinchao Gu; Huseyin Sumer; Brett Cromer
Journal:  Methods Mol Biol       Date:  2022

Review 3.  The Past, Present, and Future of Non-Viral CAR T Cells.

Authors:  Alex Moretti; Marianna Ponzo; Charles A Nicolette; Irina Y Tcherepanova; Andrea Biondi; Chiara F Magnani
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

4.  Monoclonal antibodies expression improvement in CHO cells by PiggyBac transposition regarding vectors ratios and design.

Authors:  Samira Ahmadi; Fatemeh Davami; Noushin Davoudi; Fatemeh Nematpour; Maryam Ahmadi; Saeedeh Ebadat; Kayhan Azadmanesh; Farzaneh Barkhordari; Fereidoun Mahboudi
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

5.  Generation of non-viral, transgene-free hepatocyte like cells with piggyBac transposon.

Authors:  Hokahiro Katayama; Kentaro Yasuchika; Yuya Miyauchi; Hidenobu Kojima; Ryoya Yamaoka; Takayuki Kawai; Elena Yukie Yoshitoshi; Satoshi Ogiso; Sadahiko Kita; Katsutaro Yasuda; Naoya Sasaki; Ken Fukumitsu; Junji Komori; Takamichi Ishii; Shinji Uemoto
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

Review 6.  Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy.

Authors:  Ewelina Grywalska; Barbara Sosnowska-Pasiarska; Jolanta Smok-Kalwat; Marcin Pasiarski; Paulina Niedźwiedzka-Rystwej; Jacek Roliński
Journal:  Cells       Date:  2020-04-16       Impact factor: 6.600

7.  A piggyBac-based TANGO GFP assay for high throughput screening of GPCR ligands in live cells.

Authors:  Fei Li; Xi Jiang; Ling-Ling Luo; Yue-Ming Xu; Xing-Xu Huang; Cheng Huang; Yu Zhang
Journal:  Cell Commun Signal       Date:  2019-05-23       Impact factor: 5.712

Review 8.  Recent updates on CAR T clinical trials for multiple myeloma.

Authors:  Quande Lin; Juanjuan Zhao; Yongping Song; Delong Liu
Journal:  Mol Cancer       Date:  2019-11-05       Impact factor: 27.401

Review 9.  Genome-based therapeutic interventions for β-type hemoglobinopathies.

Authors:  Kariofyllis Karamperis; Maria T Tsoumpeli; Fotios Kounelis; Maria Koromina; Christina Mitropoulou; Catia Moutinho; George P Patrinos
Journal:  Hum Genomics       Date:  2021-06-05       Impact factor: 4.639

10.  Efficient Nonviral Stable Transgenesis Mediated by Retroviral Integrase.

Authors:  Chang-Ying Chiang; Gloria Denise Ligunas; Wei-Chun Chin; Chih-Wen Ni
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-03       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.